53
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Major diabetes-related vascular events do not improve glycaemic control in a population-based cohort of type 1 diabetic individuals

, , , , &
Pages 748-751 | Received 16 Feb 2009, Accepted 07 Jun 2009, Published online: 25 Nov 2009

References

  • The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47:1703–20.
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
  • Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice, or delivery of care? BMJ. 1993;306:630–4.
  • The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–83.
  • Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med. 1991;230:101–8.
  • Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of micro vascular complications of diabetes mellitus. N Engl J Med. 1993;329:304–9.
  • Jorde R, Sundsfjord J. Intra-individual variability and longitudinal changes in glycaemic control in patients with Type 1 diabetes mellitus. Diabet Med. 2000;17:451–6.
  • Gerstl EM, Rabl W, Rosenbauer J, Grobe H, Hofer SE, Krause U, Holl RW. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr. 2008;167:447–53.
  • Jørgensen LG, Petersen PH, Heickendorff L, Møller HJ, Hendel J, Christensen C, Schmitz A, Reinholdt B, Lund ED, Christensen NJ, Hansen EK, Hastrup J, Skjødt H, Eriksen EW, Brandslund I. Glycemic control in diabetes in three Danish counties. Clin Chem Lab Med. 2005;43:1366–72.
  • Blanchard CM, Denniston MM, Baker F, Ainsworth SR, Courneya KS, Hann DM, Gesme DH, Reding D, Flynn T, Kennedy JS. Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav. 2003;27:246–56.
  • Ockene JK, Hosmer DW, Williams JW, Goldberg RJ, Ockene IS, Raia TJ 3rd. Factors related to patient smoking status. Am J Public Health. 1987;77:356–7.
  • Grauslund J, Green A, Sjolie AK. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia. 2008;51:583–8.
  • Green A, Hauge M, Holm NV, Rasch LL. Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia. 1981;20:468–70.
  • Sjolie AK. Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl. 1985;172:1–77.
  • Ekstrand A, Groop L, Pettersson E, Grönhagen-Riska C, Laatikainen L, Matikainen E, Seppäläinen AM, Laasonen E, Summanen P, Ollus A, . Metabolic control and progression of complications in insulin-dependent diabetic patients after kidney transplantation. J Intern Med. 1992;232:253–61.
  • Agardh CD, Agardh E, Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract. 1997;35:113–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.